BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nuvo Research Inc. 

1405 Denison Street

Markham  Ontario  L3R 5V2  Canada
Phone: 905-415-1446 or 1-888-398-3463 Fax: 905-415-1440


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Nuvo Research Inc. (NRI.TO) Announces Director Election Results Of Its Annual General Meeting 5/14/2015 10:54:19 AM
Nuvo Research Inc. (NRI.TO) Announces 2015 First Quarter Results 5/13/2015 6:57:09 AM
Nuvo Research Inc. (NRI.TO) Announces New WF10 Phase 2 Trial 4/22/2015 11:18:24 AM
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015 7:29:05 AM
Nuvo Research Inc. (NRI.TO) Provides Business Update 3/5/2015 9:25:24 AM
Nuvo Research Inc. (NRI.TO) Announces 2014 Fourth Quarter & Year-End Results 2/20/2015 8:47:14 AM
Nuvo Research Inc. (NRI.TO) Reports Topline Results Of Phase 2 Study Of WF10™ For The Treatment Of Allergic Rhinitis 1/30/2015 7:41:59 AM
Nuvo Research Inc. (NRI.TO) Granted Additional U.S. Patent For Treatment Of Allergic Rhinitis With WF10 12/22/2014 8:05:10 AM
Nuvo Research Inc. (NRI.TO) Reports That All Patients Have Completed Phase 2 Study Of WF10 For The Treatment Of Allergic Rhinitis 12/18/2014 7:53:31 AM
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014 9:10:09 AM
12345678910...